Search

everythinglearnresearchcommunity

for

Search:↓

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

The document's content could not be processed.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

A specific mutation in PA-PLA1α causes abnormal hair growth.

Four antibodies were developed to help study hair follicle cell differentiation.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Adalimumab may cause severe hair loss in some patients.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Low PON1 levels may indicate and predict the severity of hair loss.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Baricitinib is a promising treatment for alopecia areata.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

The ABHRS exam will be available online in 2021.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Igf1r helps regulate hair growth cycles.

Hair evaluation is crucial for early diagnosis and management of ARCI, as hair loss often indicates severity.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

5-ARI therapy may help prevent prostate cancer progression.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Baricitinib is the most effective treatment for alopecia areata.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Abietic acid from pine rosin can effectively fight and reduce harmful skin microbes.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

The ABHRS has outlined its goals for the next year.

Baricitinib helps with early hair regrowth in people with alopecia areata.

A new compound effectively inhibits human 5α-reductase 1.